Reducing Obesity & Healthcare Costs with GLP-1s 🩺🍏

This presentation explores the transformative potential of GLP-1 medications in addressing obesity, a critical health and economic challenge. Topics include obesity prevalence, associated healthcare costs, and limitations of traditional weight-loss strategies. We delve into the mechanisms and demonstrated efficacy of GLP-1 drugs like Tirzepatide and Semaglutide, their impact on chronic disease reduction, and economic benefits such as healthcare savings. Critiques, including costs and...